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Abstract
Background: In Vietnam the blackwater fever syndrome (BWF) has been associated with malaria
infection, quinine ingestion and G6PD deficiency. The G6PD variants within the Vietnamese Kinh
contributing to the disease risk in this population, and more generally to haemoglobinuria, are
currently unknown.
Method: Eighty-two haemoglobinuria patients and 524 healthy controls were screened for G6PD
deficiency using either the methylene blue reduction test, the G-6-PDH kit or the micro-
methaemoglobin reduction test. The G6PD gene variants were screened using SSCP combined
with DNA sequencing in 82 patients with haemoglobinuria, and in 59 healthy controls found to be
G6PD deficient.
Results: This study confirmed that G6PD deficiency is strongly associated with haemoglobinuria
(OR = 15, 95% CI [7.7 to 28.9], P < 0.0001). Six G6PD variants were identified in the Vietnamese
population, of which two are novel (Vietnam1 [Glu3Lys] and Vietnam2 [Phe66Cys]). G6PD
Viangchan [Val291Met], common throughout south-east Asia, accounted for 77% of the variants
detected and was significantly associated with haemoglobinuria within G6PD-deficient ethnic Kinh
Vietnamese (OR = 5.8 95% CI [114-55.4], P = 0.022).
Conclusion: The primary frequency of several G6PD mutations, including novel mutations, in the
Vietnamese Kinh population are reported and the contribution of G6PD  mutations to the
development of haemoglobinuria are investigated.
Background
Deficiency of glucose-6-phosphate dehydrogenase
(G6PD) is one of the most common enzymatic disorders
of red blood cells in humans and has a varied clinical pres-
entation [1]. The World Health Organization has defined
the different G6PD variants according to the magnitude of
the enzyme deficiency and the severity of haemolysis. The
clinical expression of G6PD deficiency varies from severe
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enzyme deficiency to increased enzyme activity (class I to
class V). The commonest clinical patterns are; 1) neonatal
jaundice, 2) congenital haemolytic anaemia, 3) drug-
induced haemolysis and 4) favism.
G6PD is the initial enzyme involved in the pentose phos-
phate pathway of erythrocyte metabolism. It is involved
in the production of NADPH and indirectly of reduced
glutathione necessary for the protection of the cells from
oxidative stress. This enzyme is encoded by the G6PD
gene, which is located at chromosome Xq28. The G6PD
gene exhibits remarkable polymorphism in human popu-
lations and G6PD is known to have over 400 variants.
These variants are distinguished by their electrophoresis
and biochemical characteristics and some variants are not
associated with significantly reduced enzyme activity in
erythrocytes [2]. However, there are numerous mutations
found in the G6PD gene, which are geographically iso-
lated and cause a deficiency of the enzyme in erythrocytes
[3-8]. Almost all G6PD deficiencies are caused by a point
mutation of the genomic DNA resulting in an amino acid
substitution [9]. To date, 140 mutations of the G6PD gene
have been identified.
The incidence of G6PD deficiency is high in malaria
endemic areas. There is evidence to support the hypothe-
sis that G6PD deficiency confers a protective effect against
illness following Plasmodium infection and genetic varia-
bility maintained at the G6PD locus appears to be an
example of a balanced polymorphism [1]. In Africa and
Southeast Asian countries where Plasmodium falciparum is
endemic, the incidence of G6PD deficiency is estimated to
be more than 10% (summarized by Matsuoka, 2005[10]).
In contrast, in Japan, Northern China and Northern Euro-
pean countries, where malaria is historically not endemic,
the incidence of G6PD deficiency is less than 0.1% (sum-
marized by Matsuoka, 2005[10]). In the northern Viet-
namese population, the incidence of G6PD deficiency is
highly variable between ethnicities. The frequency of
G6PD deficiency in the Kinh and the Mong ethnic groups,
who traditionally have lived outside malaria transmission
areas, is low (0.5% and 0.7%, respectively). The preva-
lence among ethnic groups living in the foothills of 4
provinces in the north of Vietnam (Thanh Hoa, Son La,
Ha Giang, and Hoa Binh), the breeding area of the main
malaria vector Anopheles minimus, ranges from 9.7% to
31% [11].
The blackwater fever (BWF) syndrome is characterized by
severe intravascular haemolysis and anaemia producing
dark urine in patients, and is also associated with malaria
[12,13]. The pathogenesis of BWF remains unclear
[14,15]. However, G6PD deficiency has been identified as
a cause of haemolysis in patients receiving primaquine, or
other oxidant drugs, and it is the single factor most often
associated with acute intravascular haemolysis [3,4,8,16-
18]. Chau et al showed in Vietnam that BWF was associ-
ated with quinine ingestion, malaria infection and G6PD
deficiency, and that these three factors were not mutually
independent and may interact [19]. The nature of the
interaction is unclear, particularly as quinine is not an oxi-
dant drug, like primaquine, known to cause haemolysis in
G6PD deficiency. However, the overlapping risk factors
suggest that haemoglobinuria caused by G6PD deficiency
should not be regarded as a separate syndrome [19].
Though the prevalence of G6PD deficiency in Vietnamese
populations has been reported, the genetic variants
responsible for this deficiency and their associations with
haemoglobinura have not been determined. G6PD muta-
tions were screened in patients with haemoglobinuria and
in G6PD deficient healthy individuals to identify the
G6PD variants causing G6PD deficiency in the Vietnam-
ese general population and to investigate the contribution




Three separate sample groups were collected from the
Kinh and S'tieng ethnic groups at different times in Viet-
nam. Ethnicity was self-reported by the individuals
enrolled in the study. The first group comprised of 266
healthy Vietnamese Kinh who lived in Ho Chi Minh City
(HCMC; male N = 162, female N = 98, not recorded N =
4). In 2000, venous blood (5 ml) was collected in EDTA
anticoagulant and G6PD deficiency was determined by
the methylene blue reduction test [20]. From the remain-
ing EDTA blood sample (3 ml) the plasma was removed
and the cell pellet was stored at -20°C.
The second group comprised of 258 healthy Vietnamese
S'tieng who lived in Binh Phuoc province. Finger prick
blood samples were taken in 2001 and the level of G6PD
was determined by the G-6-PDH kit (Sigma diagnostics,
UK) according to the manufacturer's specification. The
control samples used for this assay were healthy individu-
als with known G6PD deficiency. The remaining whole
blood was stored at -20°C.
The third group was comprised of 82 patients with hae-
moglobinuria admitted to the Hospital for Tropical Dis-
eases (HTD) HCMC between 1993 and 1996 [19] (male
N = 75, female N = 5, not recorded N = 2). Macroscopi-
cally haemoglobinuria was defined as patients who had
passed red or black urine. Microscopically haemoglobinu-
ria was defined as a range of 0.1–1.8 g/dl of free Hb in
urine, or Hb in the urine detected by Combur 9 Test Strips
(3+ to 4+; Roche Diagnostics). Venous blood (2 ml) was
taken from these patients and the level of G6PD was deter-Malaria Journal 2009, 8:152 http://www.malariajournal.com/content/8/1/152
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mined by screening RBCs using the micro-methaemo-
globin reduction test [21]. All patients were investigated
for the presence of malaria by thick and thin peripheral
blood smears. 21/80 patients had confirmed malaria by
the ParaSight F test, that detects P. falciparum HRP2. 15 of
these 21 patients also had positive smears for P. falciparum
and one was positive for both P. falciparum and P. vivax on
admission to HTD. 5/21 patients had a positive blood
smear result from the referring hospital but were negative
on admission at HTD. Plasmodium falciparum trophozoites
per microlitre of blood ranged from 20 to 75,360 (mean:
17615 per/μl). Transmission of malaria at the time of this
study in this area of southern Vietnam occurs sporadi-
cally. The malaria patients in this study could therefore be
defined as non-immune or partially immune individuals.
Patients were then divided into two groups; haemoglob-
inuric patients with G6PD deficiency and haemoglobinu-
ric patients without G6PD deficiency. 48/82
haemoglobinuric patients were defined as G6PD deficient
based on a methaemoglobin reduction test of <5 at hospi-
tal admission (number of tests performed at admission N
= 79) and discharge [number of tests performed at dis-
charge N = 68; discharge at <1 week (N = 24), 1–2 weeks
(N = 37), >2 weeks (N = 7)]. 35/82 haemoglobinuric
patients had a further methaemoglobin reduction test at
follow up (follow up was at >54 days post hospital admis-
sion and ranged from 54–365 days). From the follow up
test 23 were confirmed as G6PD deficient. Therefore in
this study 48/82 haemoglobinuric patients are defined as
"probable G6PD deficient" and 23/82 are defined as "def-
inite G6PD deficient". Plasma was removed from the
remaining blood sample and the blood cell pellet was
stored at -20°C.
DNA extraction
DNA was extracted from frozen blood cell pellets or whole
blood by the Nucleon genomic DNA extraction Kit (Tep-
nel Life Sciences, United Kingdom).
DNA fragment amplification
Primers were designed to PCR amplify all 13 exons of the
G6PD gene (table 1). The complete exonic regions were
generated in 14 fragments ranging between 150–400 bp
in length. PCR was performed in a 25 μL reaction contain-
ing 25 μM of each specific primer, 0.2 mM of each dNTP,
1 – 2.5 mM MgCl2, approximately 100 ng of DNA and 1
unit of AmpliTaq polymerase (Applied Biosystems, USA).
PCR cycling conditions were as follows; 95°C for 5 min,
annealing temperature (see Table 1) for 1 min then 30
cycles of 72°C for 1 min, 95°C for 30 s, annealing temper-
Table 1: The primers and annealing temperatures used for PCR to amplify and sequence the exons of the G6PD gene
Exons PCR product size (bp) PCR anealing temperature (°C) Primers
1A 305 62 F 5'-CTTGAACCCGCGAACAGGCGA
R 5'-TCTCGGGCACCTGCGCTGGA
1B 365 68 F 5'-GCAGAGCAGCGGCAGCGGGTAT
R 5'-TATTTTACCGCCGCGCGGCGCA
2 241 65 F 5'-CTCAAGAAAGGGGCTAACTTCTCAA
R 5'-GCACTTCCTGGCTTTTAAGATTGGG
3+4 352 60 F 5'-CAGGCCAACTTCTAACCACACACCT
R 5'-CCGAAGCTGGCCATGCTGGG
5 295 65 F 5'-CTGTCTGTGTGTCTGTCTGTCC
R 5'-GGCCAGCCTGGCAGGCGGGAAGG
6 264 58 F 5'-ACTCCCCGAAGAGGGGTTCAAGG
R 5'-GAGGCTCCTGAGTACCACCC
7 234 65 F 5'-CAAGGTCAGTTCCTCCACCTTGCC
R 5'-GAAGAGTAGCCCTGCAGGGTGACT
8 164 72 F 5'-GGAGCTAAGGCGAGCTCTGGC
R 5'-GGCATGCTCCTGGGGACTGGG
9 253 72 F 5'-CAAGGAGCCCATTCTCTCCCTT
R 5'-TGCCTTGCTGGGCCTCGAAGG
10 318 72 F 5'-CTGAGAGAGCTGGTGCTGAGG
R 5'-AGGCCGCCCACCCTCCACACT
11 160 65 F 5'-GCAGGCAGTGGCATCAGCAAG
R 5'-CCCCATAGCCCACAGGTATGCAGG
12+13A 368 72 F 5'-TGTGTGCCACCGGCCTCCCA
R 5'-GGGAAGGAGGGTGGCCGTGG
13B 364 68 F 5'-GTGGGTGAACCCCCACAAGGTC
R 5'-TGGCCCCACTCAGGAGTGAGAC
13C 377 68 F 5'-CCATTCGTCTGTCCCAGAGCTTA
R 5'-TGGGACAAGGAAGTGGGTCCTCAMalaria Journal 2009, 8:152 http://www.malariajournal.com/content/8/1/152
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ature for 1 min, and then 72°C for 5 min once. PCR prod-
ucts were separated on a 2% agarose gel containing 1 μg/
ml ethidium bromide and bands were visualized by ultra-
violet illumination (for specific PCR product sizes see
Table 1).
Mutation detection by single-strand conformation 
polymorphism (SSCP)
PCR products were analysed by SSCP to detect mutations.
Sequence variation can be recognized by band size
changes on polyacrylamide gel (Figure 1), when compar-
ing bands to a wild type control. PCR products were dena-
tured at 80°C for 10 min prior to polyacrylamide gel
electrophoresis. 5 μl of the denatured PCR product was
mixed with loading buffer (98% formamide, 0.025%
xylene cyanol FF and 0.025% bromophenol blue). The
samples were separated on 6–8% polyacrylamide gels
(acrylamide and bisacrylamide at a ratio of 99:1) in a tris
borate buffer (TBE) containing 5% glycerol. If fragments
were not separated effectively then the ratio of acrylamide
to bisacrylamide was altered (39:1 or 19:1) and the per-
centage of glycerol was increased to 10%. Gels were elec-
trophoresed in a vertical tank (Gibco BRL Sequencing
System) at a constant power of 4W for 18 hours at 4°C.
Gels were silver stained by standard procedures and then
dried onto Whatman 3 MM paper using a vacuum gel
drier.
Cloning and DNA sequencing
Two or three samples for each unusual band pattern
detected on an SSCP gel were prepared for sequencing to
confirm the location of the sequence change. The PCR
products were gel purified using a Geneclean kit (BIO
101, USA) and then cloned using the TOPO TA Cloning
kit for Sequencing (Invitrogen, UK). Cloned plasmids for
sequencing were extracted from Escherichia coli by the Per-
fectprep Plasmid Mini Kit (Eppendorf, Germany). PCR
products that were sequenced directly where purified
using the QIAquick PCR Purification kit (Qiagen, UK).
Plasmid DNA templates were sequenced using the M13
forward and reverse primers, whereas PCR templates were
sequenced using the specific primers that had initially
generated the PCR fragment (Table 1). DNA sequencing
was performed on a CEQ8000 capillary sequencer (Beck-
man, Singapore). The sequence of each sample was com-
pared to the sequence of G6PD in GenBank (accession
No. X55448) to identify the mutations.
Statistical analysis
Fisher's exact test was used for all comparisons and was
performed within the STATA software package.
Results
Phenotypic screening for G6PD deficiency in healthy indi-
viduals from two ethnic groups, the Vietnamese Kinh and
S'tieng, showed that the overall prevalence of the G6PD
deficient phenotype in the southern Vietnamese popula-
tion is relatively high at 11.3% (59/524). The difference in
the prevalence of G6PD deficiency between the two Viet-
namese ethnicities was not significant; 8.7% (23/266) in
the Kinh and 14% (36/258) in the S'tieng (p = 0.07). Of
the 23 G6PD deficient Kinh, 17 were male, five were
female and one unknown (sex not recorded). Of the 36
G6PD deficient S'tieng, 28 were male and eight were
female. In Vietnamese Kinh patients with haemoglobinu-
ria, the frequency of "probable G6PD deficiency" was
58.5% (48/82). Twenty-eight percent (23/82) of haemo-
globinuric patients had "definite G6PD deficiency." Of
the 82 haemoglobinuric patients, five were female and 75
were male. All patients with probable G6PD deficiency
were male (N = 48).
To identify the molecular cause of G6PD deficiency in this
population the G6PD gene was screened for mutations in
healthy individuals (of both Kinh and S'tieng ethnic
groups) who were G6PD deficient, and in all haemoglob-
inuric patients (N = 82). Across the three groups eight pol-
ymorphisms were identified within the G6PD gene (Table
2). Five of these variants have been described in other
populations, namely Gaohe Gaozhou (A95G; His32Arg),
Coimbra "Shunde" (C11763T; Arg198Cys), Chinese-5
(C13184T; Leu342Phe), and Viangchan Jammu
(G13031A; Val291Met) and nt13714C>T [9]. Three vari-
ants identified in this Vietnamese population are novel
(two non-synonymous polymorphisms and one silent):
Vietnam1 (G7A; Glu3 Lys); Vietnam2 (T10148G; Phe66
Cys); and Vietnam3 (C10170 T, Ser73 Ser) (Table 2).
In the healthy G6PD deficient group (both Kinh and
Stieng) 37.3% (22/59) have no detectable mutation in the
Detection of G6PD variants by SSCP Figure 1
Detection of G6PD variants by SSCP. Different banding 
patterns, compared to the wild-type pattern, represent the 
presence of DNA sequence variation. Ld denotes 100 bp lad-
der. Lane 2 is the wild-type pattern.
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G6PD gene and 28.8% (17/59) have a synonymous poly-
morphism only. 33.9% (20/59) of the healthy G6PD defi-
cient group have detectable non-synonymous G6PD
variants. In the haemoglobinuria group, 25.6% (21/82) of
patients harbour non-synonymous polymorphisms in the
G6PD gene. Within the haemoglobinuria group of those
patients with measured G6PD deficiency 39.6% (19/48)
harboured non-synonymous G6PD polymorphisms, and
14/48 had a synonymous polymorphism (9/48 of these
patients harboured both synonymous and non-synony-
mous  G6PD  polymorphisms). In contrast the patients
without measured G6PD deficiency harboured signifi-
cantly fewer non-synonymous G6PD polymorphisms (2/
34 (6%), P = 0.001) but a similar number of synonymous
polymorphisms (10/34 (29%), P = 1.0).
The most common polymorphism found in this study
was the synonymous polymorphism nt13714C>T (C
13714 T; Tyr437Tyr). 42.1% (45/107) of G6PD deficient
individuals in the Vietnamese population had this poly-
morphism and 29.3% (24/82) in the haemoglobinuria
group. The second most common polymorphism found
in this study was the Viangchan variant; 36% (13/36) of
healthy G6PD deficient S'tieng, 9% (2/23) of healthy
G6PD deficient Kinh and 22% (18/82) of Kinh with hae-
moglobinuria (35.4% with G6PD deficiency and 2.9%
without).
Comparing the frequencies of G6PD deficiency in healthy
Kinh and haemoglobinuric Kinh (table 3) demonstrates
that G6PD deficiency is significantly associated with hae-
moglobinuria in the Kinh [comparison of "probable
G6PD deficient" haemoglobinuric patients to healthy
controls, OR = 14.9, 95%CI (7.7 to 28.9), P < 0.0001;
comparison of "definite G6PD deficient" haemoglobinu-
ric patients to healthy controls, OR = 4.11, 95%CI (2.04
to 8.34), P < 0.0001]. Some other possible reasons for
haemoglobinuria other than G6PD deficiency in this
patient population are malaria, anti-malarial treatment
(quinine), other treatment, other infections (two patients


















G7A Vietnam 1 Glu3Lys * 1
A95G Gaohe Gaozhou His32Arg 3 1
T10148G Vietnam 2 Phe66Cys * 1
C11763T Coimbra Shunde Arg198Cys 2 1 1
G13031A Viangchan Jammu Val291Met 3,2 1 17 2 13
C13184T Chinese-5 Leu342Phe 3 0 1 3 1
synonomous
C10170T Vietnam 3 Ser73Ser 1
C13714T nt13714C>T Tyr437Tyr 10 14 9 21
The variant genomic positions are based on the GenBank sequence (accession no. genX55448X55448).
a class 1 = hereditary nonspherocytic haemolytic anaemia; class 2 = severe deficiency; class 3 = mild deficiency; class 4 = non-deficient; * unknown









OR 95%CI P value
deficiencya 48 23 14.9 7.74 – 28.9 < 0.0001
definiteb 23 23 4.11 2.04–8.24 < 0.0001
Viangchan Jammu 17 2 5.7 1.14 – 55.4 0.022
Chinese-5 1 3 0.14 0.002 – 1.9 0.09
Vietnam 1 1 0
Gaohe Gaozhou 1 0
Vietnam 2 0 1
a deficiency includes definite and probable G6PD deficiency
b definite includes all cases with long term follow up that have confirmed G6PD deficiency
c haemoglobinuriaMalaria Journal 2009, 8:152 http://www.malariajournal.com/content/8/1/152
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had possible leptospirosis and two with possible sepsis)
and thalassemia (one patient)".
The frequency of the most common non-synonymous
G6PD mutation (Viangchan) was significantly higher in
G6PD deficient Kinh with haemoglobinuria than in
G6PD-deficient healthy Kinh (OR = 5.7, 95%CI [1.14 to
55.4], P = 0.022). The Chinese-5 mutation has a low fre-
quency in this population and the frequency was not sig-
nificantly different between G6PD deficient Kinh with
haemoglobinuria and G6PD deficient healthy Kinh (OR =
0.14, 95%CI [0.002 to 1.9], P = 0.09). Two variants,
Vietnam1 and Gaohe Gaozhou, were only seen in the
G6PD deficient Kinh with haemoglobinuria and not in
the G6PD deficient healthy Kinh. In contrast, G6PD
Vietnam2 was only seen in the G6PD deficient healthy
Kinh group.
Table 4 summarizes the frequency of other factors that
have previously been related to the development of hae-
moglobinuria and more specifically BWF. 58.5% of the
patients with haemoglobinuria were G6PD deficient,
25.6% had malaria confirmed by a positive blood smear
and 17% received anti-malarial treatment (either quinine
or primaquine). The percentage of patients with haemo-
globinuria that had non-synonymous mutations resulting
in mild to severe G6PD deficiency was 25.6%.
Discussion
The frequency of G6PD deficiency in Southeast Asia is
highly variable [22]. Within Vietnam the incidence of
G6PD deficiency varies between the northern and south-
ern areas and among ethnicities. In southern Vietnam,
there is a high prevalence of G6PD deficiency in ethnic
Kinh (8. 7%) and S'tieng (14%), who live in areas which
are or were until recently highly endemic for malaria. In
northern Vietnam, where malaria transmission is lower,
G6PD deficiency is virtually absent [11].
Studies have shown that the distribution of G6PD variants
also vary with geographical area and/or ethnic group.
Matsuoka et al has reported that nine variants are present
in China, nine in Malaysia, five in Thailand and four in
Myanmar [23]. In Vietnam at least seven variants have
been reported [23]. In this study, eight different polymor-
phisms were identified of which six resulted in an amino
acid substitutions and three were novel mutations. The
major G6PD variants reported in south-east Asian coun-
tries are G6PD Viangchan (G13031A) and G6PD Mahidol
(G11658A). Almost all of the G6PD-deficient cases
detected in Laos [22], Cambodia [10,24], Thailand
[25,26] and Malaysian Malays [27] are G6PD Viangchan,
while G6PD Mahidol is the most common variant in
Myanmar [22,28,29]. G6PD Mahidol is also common in
Thailand [25,30] and Malaysia [27].
In Vietnam, the G6PD Viangchan is the most common
variant. A previous study in Lam Dong province also
reported that G6PD Viangchan is the dominant G6PD
variant in the Vietnamese population [23]. It can be
hypothesized that the strong historical connection
between Vietnam and China has resulted in the presence
of common Chinese variants, such as Gaohe Gaozhou,
Chinese-5 and Coimbra "Shunde" [31], in this Vietnam-
ese population. Interestingly, the G6PD Mahidol muta-
tion was not seen in this Vietnamese population. This is
different from Thailand and Myanmar [29], where G6PD
Mahidol is common. Notably, in this study, two novel
non-synonymous variants (Vietnam1 and Vietnam2) and
one novel silent polymorphism (Vietnam3) were identi-
fied. Even though the frequencies of these mutations are
low, it is possible that a new generation of G6PD muta-
tion is occurring in the Vietnamese population.
Studies in Southeast Asia report that G6PD Viangchan is
in linkage disequilibrium with the silent polymorphism
nt13714C>T [22,26,27]. In this study, 72.7% (24/33) of
the subjects that harbour Viangchan also harbour
nt13714C>T. The interpretation of these results could
either be that the linkage disequilibrium between
Viangchan and nt13714C>T is not absolute in the Viet-
namese, or that detection of the nt13714C>T polymor-
Table 4: The frequency of factors that may contribute to the development of haemoglobinuria in the Vietnamese cohort
Haemoglobinuria Kinh N = 82 Healthy Kinh N = 266 Healthy S'tieng N = 258
G6PD deficiencya 48 (58.5) 23 (8.65) 36 (13.95)
Suspected malariab 34 (41.5)
Confirmed malariac 21(25.6)
Received anti-malarialsd 14 (17)
Harbour G6PD polymorphisme 34 (41.5) 14 (0.05) 23 (0.09)
Harbour G6PD non-synonomous mutation 21(25.6) 6 (0.02) 14 (0.05)
Harbour G6PD published mutation 20 (24.4) 6 (0.02) 14 (0.05)
a deficiency includes definite and probable G6PD deficiency
b patients that are smear positive for malaria and patients that have been on anti-malarial treatment
c patients that are smear positive for malaria only
d patients that have received either quinine or primaquine anti-malarial treatment
e individuals that harbour 1 or more polymorphismMalaria Journal 2009, 8:152 http://www.malariajournal.com/content/8/1/152
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phism by SSCP was not 100% sensitive. Findings to
support the later are that the G6PD Viangchan mutation
was demonstrated to be completely co-inherited with the
silent polymorphism nt13714C>T in a previous study in
the Vietnamese population [23]. Matsuoka et al [23] also
found six previously published variants (Gaohe, Quing
Yuan, Union, Canton, Kaiping and Bao Loc) in the Viet-
namese Kinh of Lam Dong province. Of these, only the
G6PD Gaohe variant was detected in this cohort of Viet-
namese Kinh. In addition, 38% (41/107) of G6PD defi-
cient people in this study had no identifiable mutation in
the G6PD gene. Even though three novel G6PD variants
were identified in this study, the SSCP method used may
not have been a sensitive enough method to detect all
mutations that exist in the population. In the future, direct
sequencing of the G6PD gene would improve the sensitiv-
ity to detect G6PD variants. Alternatively some of these
patients may not truly be G6PD deficient. There are two
limitations of this study regarding the ascertainment of
G6PD deficiency. Firstly, three different tests were used in
the three subject groups, which were collected at different
points in time, and in two different locations. This is not
ideal, however in Vietnam, a rapidly developing nation,
resources can vary over time. The use of two screening
tests (methaemoglobin reduction test and methylene blue
reduction test) may have lead to a reduction in sensitivity.
Secondly, the specificity of the G6PD testing of haemo-
globinuric patients may have been compromized, as the
results depend on the time between haemolysis and the
performance of the test. For the majority of haemoglob-
inuric patients screening for G6PD deficiency took place
on hospital admission and at the time of discharge, so
mis-classification could have occurred depending on the
period between haemolysis and testing. A smaller subset
of patients had further testing at follow up (>54 days post
hospital admission), a time where G6PD testing would
have been accurate. Therefore it could be a combination
of the SSCP method lacking sensitivity and sub-optimal
G6PD testing that is responsible for the lack of identifia-
ble mutations in the G6PD gene in individuals deemed
G6PD deficient in this study.
BWF has been associated with recent or active malaria,
and with the ingestion of oxidant drugs such as pri-
maquine. 25.6% of the patients with haemoglobinuria
had confirmed malaria. In this Vietnamese Kinh cohort,
the association between G6PD deficiency and haemo-
globinuria was strong. The association between G6PD
deficiency and haemolysis has been shown in at least four
clinical syndromes, oxidative stress-induced haemolysis,
favism, neonatal jaundice and chronic non-spherocytic
haemolytic anaemia [26].
Of the G6PD variants, only G6PD Viangchan was shown
to be associated with haemoglobinuria in the Kinh group.
The G6PD Viangchan variant is one of the class 2 G6PD
variants known to be associated with chronic haemolytic
anaemia (according to Beutler, 1994 [32]). The frequency
of the Chinese-5 variant, as well as other variants that
result in a severe to mild enzyme deficiency, is low in the
population, so comparisons are statistically unreliable.
Currently, the rarity of haemoglobinuric patients from
malaria endemic regions of Vietnam leaves one unable to
expand these studies in a larger sample set.
The haemoglobinuric patients investigated in this study of
G6PD variation were hospitalized between 1993 and
1996. Since the early 2000s it has been rare for the Hospi-
tal for Tropical Diseases in HCMC to admit patients with
haemoglobinuria associated with malaria. This is may be
related to a change in the treatment policy for malaria in
Vietnam. In 1990 the first intervention trial investigating
the use of artemisinin derivatives for the treatment of
malaria in southern Vietnam was published [33]. Follow-
ing the success of this and subsequent trials, artesunate
replaced quinine in the national recommendations for the
treatment of malaria in Viet Nam from 1998 onwards.
After this date very little quinine has been used in Viet
Nam. It is possibly this change in treatment for malaria
from quinine to the artemisinin derivatives that has lead
to significantly less drug induced haemolysis in Vietnam-
ese individuals that are G6PD-deficient and infected with
malaria.
Conclusion
This study reports the primary frequency of several G6PD
mutations in Vietnam. G6PD Viangchan, a common
south-east Asian variant, was found to be the most preva-
lent and two novel non-synonymous variants (Vietnam1
and Vietnam2) and one silent polymorphism (Vietnam3)
were identified in this Vietnamese population. G6PD defi-
ciency is a major risk factor for haemoglobinuria in Viet-
namese Kinh and within the G6PD deficient population
G6PD Viangchan was significantly associated with hae-
moglobinuria.
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